enVVeno Medical Corporation NVNO
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -28.58% | -11.72% | -8.28% | -2.43% | 10.96% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -27.42% | -15.34% | -13.54% | -1.94% | 6.03% |
| Operating Income | 27.42% | 15.34% | 13.54% | 1.94% | -6.03% |
| Income Before Tax | 31.84% | 11.78% | 10.76% | -3.42% | -11.99% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 31.84% | 11.78% | 10.76% | -3.42% | -11.99% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 31.84% | 11.78% | 10.76% | -3.42% | -11.99% |
| EBIT | 27.42% | 15.34% | 13.54% | 1.94% | -6.03% |
| EBITDA | 27.46% | 15.25% | 13.43% | 1.71% | -6.36% |
| EPS Basic | 40.38% | 24.51% | 25.63% | 19.01% | 15.53% |
| Normalized Basic EPS | 36.02% | 27.93% | 29.40% | 24.83% | 21.00% |
| EPS Diluted | 40.38% | 24.51% | 25.63% | 19.01% | 15.53% |
| Normalized Diluted EPS | 36.02% | 27.93% | 29.40% | 24.83% | 21.00% |
| Average Basic Shares Outstanding | 14.24% | 16.60% | 20.15% | 27.52% | 31.05% |
| Average Diluted Shares Outstanding | 14.24% | 16.60% | 20.15% | 27.52% | 31.05% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |